EU regulator backs J&J shot, finds possible link to clotsEurope's drug regulator has found a possible link between Johnson & Johnson's (JNJ.N) COVID-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks. The E.U. will allow vaccinated Americans to visit this summerHowever, travel will be contingent on vaccination certificates showing proof of vaccination European Medicines Agency first to approve Moderna jab for childrenIt is the first time the vaccine has been authorised for people aged under 18. West Ham vs Chelsea LIVE: Latest Premier League updatesFollow the latest updates as West Ham host Chelsea in the Premier League on Saturday evening AstraZeneca vaccinations resume in Germany after clot scareGermany is resuming vaccinations with the coronavirus vaccine made by AstraZeneca after European regulators said the benefits of the shot outweigh the risks Denmark suspends use of AstraZeneca vaccine over blood clot fearsThe vaccine will not be used for 14 days while investigators probe reports of possible ‘serious side-effects’. Israel, Denmark and Austria join forces against COVID-19The leaders of Israel, Denmark and Austria say they'll work together against COVID-19, investing in research and production centers to keep up with vaccine demand Under-40s to be offered different Covid jab to AstraZeneca over blood clot fearsThe Joint Committee on Vaccination and Immunisation (JCVI) today said under-40s would be offered an alternative to the Oxford/AstraZeneca jab after 242 reports of blood clots accompanied by low blood platelet count in the UK out of around 28.5 million dos Covid vaccines put Americans on course for holidays in Europe this summerAmerican tourists vaccinated against Covid-19 may be able to visit Europe within months, Ursula von der Leyen has said.The president of the European Commission gave no timetable for lifting travel Denmark ditches Oxford-AstraZeneca vaccineDenmark has become the first country to stop using the Oxford-AstraZeneca vaccine in all age groups because of a putative link to a blood disease that the government believes to affect about one in 40